The Saudi General Authority for Competition (GAC) approved, on Oct. 6, the economic concentration arising from Dallah Healthcare Co.’s planned acquisition of a 58.64% stake in Care Shield Holding Co., a subsidiary of Kingdom Investment and Development Co.
According to the data compiled by Argaam, Dallah Healthcare signed, on May 15, 2020 a final agreement to buy a 58.64% stake in Care Shield, through share swap and cash consideration.
The deal completion is still subject to a number of conditions, including, the approval of the relevant governmental authorities.
Dallah Healthcare will disclose the relevant material updates in due course.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}